A detailed history of Bnp Paribas transactions in Zoetis Inc. stock. As of the latest transaction made, Bnp Paribas holds 135,826 shares of ZTS stock, worth $22.7 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
135,826
Previous 7,640 1677.83%
Holding current value
$22.7 Million
Previous $1.24 Million 1697.67%
% of portfolio
1.0%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$156.48 - $175.67 $20.1 Million - $22.5 Million
128,186 Added 1677.83%
135,826 $22.4 Million
Q4 2024

Feb 14, 2025

SELL
$162.24 - $194.42 $10,870 - $13,026
-67 Reduced 0.87%
7,640 $1.24 Million
Q3 2024

Nov 13, 2024

BUY
$172.58 - $196.48 $243,337 - $277,036
1,410 Added 22.39%
7,707 $1.5 Billion
Q2 2024

Aug 13, 2024

BUY
$145.54 - $178.83 $572,117 - $702,980
3,931 Added 166.15%
6,297 $1.09 Billion
Q1 2024

May 01, 2024

BUY
$165.67 - $199.94 $391,975 - $473,058
2,366 New
2,366 $401 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $78.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bnp Paribas Portfolio

Follow Bnp Paribas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas, based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas with notifications on news.